N. Arden

First name
N.
Middle name
K.
Last name
Arden
Smith, L. K., Garriga, C., Kingsbury, S. R., Pinedo-Villanueva, R., Delmestri, A., Arden, N. K., et al. (2022). UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national data sets tell us about mid-late term revision risk after hip replacement? Retrospective cohort study. Bmj Open, 12, e050877. http://doi.org/10.1136/bmjopen-2021-050877
Smith, L. K., Garriga, C., Kingsbury, S. R., Pinedo-Villanueva, R., Delmestri, A., Arden, N. K., et al. (2022). UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national datasets tell us about mid-late term revision risk after knee replacement?. Bmj Open, 12, e046900. http://doi.org/10.1136/bmjopen-2020-046900
Edwards, C. J., Arden, N. K., Fisher, D., Saperia, J. C., Reading, I., van Staa, T. P., & Cooper, C. (2005). The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kei024
Edwards, C. J., Cooper, C., Fisher, D., Field, M., van Staa, T. P., & Arden, N. K. (2007). The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis. Arthritis Rheum. http://doi.org/10.1002/art.23003
Culliford, D. J., Maskell, J., Beard, D. J., Murray, D. W., Price, A. J., & Arden, N. K. (2010). Temporal trends in hip and knee replacement in the United Kingdom: 1991 to 2006. J Bone Joint Surg Br. http://doi.org/10.1302/0301-620x.92b1.22654
Bolland, B. J., Culliford, D. J., Maskell, J., Latham, J. M., Dunlop, D. G., & Arden, N. K. (2011). The effect of hip and knee arthroplasty on oral anti-inflammatory use and the relationship to body mass index: results from the UK general practice research database. Osteoarthritis Cartilage. http://doi.org/10.1016/j.joca.2010.10.012
Prieto-Alhambra, D., Javaid, M. K., Judge, A., Maskell, J., Kiran, A., de Vries, F., et al. (2011). Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum. http://doi.org/10.1002/art.30214
Prieto-Alhambra, D., Javaid, M. K., Judge, A., Murray, D., Carr, A., Cooper, C., & Arden, N. K. (2011). Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. Bmj. http://doi.org/10.1136/bmj.d7222
Prieto-Alhambra, D., Javaid, M. K., Maskell, J., Judge, A., Nevitt, M., Cooper, C., & Arden, N. K. (2011). Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/ard.2010.131110
Culliford, D. J., Maskell, J., Kiran, A., Judge, A., Javaid, M. K., Cooper, C., & Arden, N. K. (2012). The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database. Osteoarthritis Cartilage. http://doi.org/10.1016/j.joca.2012.02.636